Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/31—Hydrocarbons
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
  • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
  • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
  • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
  • A23L5/40—Colouring or decolouring of foods
  • A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
  • A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
  • A23L5/44—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
  • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/67—Vitamins
  • A61K8/676—Ascorbic acid, i.e. vitamin C
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/67—Vitamins
  • A61K8/678—Tocopherol, i.e. vitamin E
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
  • A61K8/73—Polysaccharides
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
  • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
  • A61K8/9783—Angiosperms [Magnoliophyta]
  • A61K8/9789—Magnoliopsida [dicotyledons]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P17/00—Drugs for dermatological disorders
  • A61P17/16—Emollients or protectives, e.g. against radiation
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P17/00—Drugs for dermatological disorders
  • A61P17/18—Antioxidants, e.g. antiradicals
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P39/00—General protective or antinoxious agents
  • A61P39/06—Free radical scavengers or antioxidants
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
  • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin
  • A61Q19/08—Anti-ageing preparations
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
  • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
  • A23V2200/00—Function of food ingredients
  • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
  • A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat

Definitions

• the present invention relates to a natural lycopene concentrate and its process of production and its use.
• Lycopene is a natural pigment contained in a large quantity in tomatoes, but it is also present in melon, guava, watermelon or grapefruit. It is known for its bioactive properties, and in particular for its antioxidant role.
• Lycopene-containing preparations exist on the market. These preparations are generally in the form of oleoresins and the lycopene which they contain is of a relatively limited bioavailability. Furthermore, the lycopene is extracted with the aid of organic solvents; the said solvents are therefore likely to be found in the form of traces in the finished product.
• EP 1103579 describes a mixture of lycopene with a solution of serum proteins in order to increase its bioavailability.
• the lycopene described is extracted by means of a solvent.
• WO 03/041678 describes a lycopene with an increased bioavailability by virtue of the addition of various additives such as oils or surfactants.
• the lycopene described is extracted with solvents.
• JP 54024940 describes a process for concentrating lycopene from residues of tomatoes, such as the seeds or the skin. This process uses the endogenous enzymes of these residues in order to degrade the biological tissues and to facilitate the extraction of lycopene. This enzymatic activity is induced by an incubation of 5 hours at temperatures of between 45 and 60° C. The lycopene is then extracted after separation of the skins and seeds by filtration followed by fractional flocculation of the various undesirable insolubles.
• the aim of the present invention is to provide a “natural” product with increased bioavailability, that is to say that the product has only been subjected to technological treatments which do not modify its native characteristics.
• the process of extraction according to the invention is simple, rapid and economical and at no time subject to the state of viability of the endoenzymes of the raw material.
• the present invention relates to a natural lycopene concentrate, which is water-soluble at room temperature while lycopene was up until now fat-soluble. This water-solubility is obtained without adding surfactants.
• the concentrate may be obtained from any lycopene-containing plant, namely: tomato, melon, watermelon, guava, grapefruit, apricot, rosehip.
• the raw material used may be a tomato paste.
• tomato paste in the present description is understood to mean a concentrated tomato extract including proteins, carbohydrates, polysaccharides, fat-soluble compounds such as carotenoids and inter alia lycopene, and organic acids.
• the tomato paste is chosen according to its initial lycopene concentration. Indeed, the lycopene content of the concentrate depends on the initial content of this same compound in the raw material.
• the concentrate according to the invention contains at least 1 mg of lycopene per g of the said concentrate.
• the concentrate preferably contains between 1 mg and 40 mg of lycopene per g of concentrate and more preferably between 10 and 30 mg of lycopene per g of concentrate.
• the concentrate additionally contains up to 30% of proteins, up to 30% of polysaccharides, up to 10% of organic acids, at least 30% of lipid compounds and therefore between 0.0001 and 2% of lycopene and more preferably between 0.001 and 1% of lycopene.
• composition according to the invention may be provided in pulverulent, liquid or gel form.
• the said concentrate in liquid form, contains at least 35% of water.
• the said concentrate contains more preferably from 60 to 95% of water.
• the two important characteristics of this invention are having a lycopene concentrate having a satisfactory bioavailability, and being easy to use since, in the case of the powder, the concentrate is a lycopene powder which is water-soluble at room temperature, this being without using a solvent during the process in order to preserve the natural nature of the product in order to provide the consumer with a concentrate with a high bioactivity.
• the better bioavailability of the lycopene concentrate according to the invention is explained by the fact that the crystals obtained according to the process claimed have a size which is 5 to 10 times smaller than that of the crystalline forms of oleoresin. Without forgetting that the raw material used, in this case tomato paste, is the source in which lycopene is more bioavailable because of the various technological treatments to which it is subjected during its manufacture.
• oleoresin is understood to mean a plant lipid extract containing carotenoids, such as lycopene, triglycerides, phospholipids, tocopherol and other more minor compounds.
• the powder or the gel or the solution according to the invention may additionally contain vitamin E and/or vitamin C which could be added.
• the present invention also relates to the process for manufacturing the concentrate described above in which:
• a plant structure containing a lipophilic compound is alkalinized
• the alkalinized solution is heated to boiling temperature and maintained for 1 to 60 minutes,
• the fibres and various insoluble compounds are isolated by solid-liquid separation and preferably by filtration in the hot state,
• the carbohydrates and other soluble compounds are isolated by solid-liquid separation and preferably by centrifugation.
• the expression plant structure is understood to mean a paste of the said plant obtained by reducing its water content.
• a liquid is obtained.
• This liquid has a rheofluidizing behaviour and its viscosity is 90 to 120 mPa.s under a shear rate of 160 s ⁇ 1 .
• This viscosity was measured at a constant temperature of 20.5° C. with a RheoStress 150 apparatus having a Couette geometry with a shear rate increasing from 1 to 1 000 s ⁇ 1 .
• composition according to the invention may be used directly in these different forms or as a mixture.
• This preparation is mixed while heating to the boiling temperature. This boiling is maintained for 1 to 60 minutes and more preferably for 2 to 30 minutes.
• a solid-liquid separation is then carried out in order to isolate the fibres and other insoluble compounds and a filtration in the hot state is more preferably carried out.
• the filtrate recovered is a solution containing dispersed lycopene. It is acidified with an acid of the citric acid type to a pH of between 3.5 and 5 and more preferably between 4 and 4.5.
• This preparation is mixed and then a solid-liquid separation is carried out in order to recover the carbohydrates and other soluble compounds and a centrifugation is more preferably carried out.
• the solution obtained is a lycopene concentrate according to the invention. It is possible to bring the pH to neutrality with demineralized water and a base of the NaOH type, while simultaneously mixing.
• the lycopene is now water-soluble because it has formed a complex with proteins of the medium and with polysaccharides.
• the lycopene concentrate is either used as it is, in this case in liquid form, or in gel form; calcium will then be added to the complex in order to cause gelling of the polysaccharides.
• the concentrate is dried by spray-drying or any other means known to persons skilled in the art.
• the present invention also relates to the use of the powder described above in a cosmetic composition in order to slow the ageing of the skin and/or the skin damage caused by exposure to UV, the said composition containing at least 10 ⁇ 10 % of lycopene.
• composition which can be used by the topical route, may additionally contain a cosmetically acceptable fat or oil.
• a cosmetically acceptable fat or oil may also contain a structuring agent, a surfactant, excipients, colorants, perfumes, abrasives or opacifiers.
• composition according to the invention contains between 10 ⁇ 10 and 10% of lycopene, more preferably a cosmetic composition contains between 10 ⁇ 8 and 5% of lycopene.
• the present invention also relates to the use of the lycopene concentrate in compositions which can be ingested orally in order to use the high bioavailability of the lycopene in this form.
• the aim is to induce photoprotection and to slow the ageing of the skin.
• the media which are likely to contain this concentrate may be: drinks, chocolate, ice creams, cereal preparations, soluble coffee and prepared meals.
• the powder is dissolved in the relevant preparations so as to have a daily intake of between 0.001 and 50 mg of lycopene.
• the preferred daily intake will be between 2 mg and 10 mg.
• the present invention may also be provided in the form of pills, gelatin capsules or tablets containing doses of 0.001 to 100% of the said concentrate. These products may then be ingested directly with water or by any other known means.
• the concentrate may finally be envisaged as a product which prevents skin conditions linked to excessive exposure to UV.
• the use may be both by the oral and topical routes.
• examples of the present invention are as follows:
• the solution is heated to boiling temperature and this boiling is maintained for 5 minutes.
• the solution is allowed to stand for 15 minutes at room temperature, then filtered in the hot state in a Westfalia type decanter.
• the filtrate collected is cooled in water at a temperature of 15° C. This solution is mixed while acidifying with citric acid to a pH of 4.3.
• the solution is then centrifuged in a Padberg type centrifuge at 14 000 revolutions per minute.
• the supernatant is recovered and its pH is adjusted to 7.00 with NaOH.
• the solution obtained is spray-dried in a NIRO type spray-dryer with an inlet temperature of 110 to 130° C. and an outlet temperature of between 70 and 80° C.
• the speed of rotation of the spray-drying nozzle is between 24 000 and 30 000 revolutions per minute depending on the desired powder fineness.
• the concentrate according to the invention is then recovered.
• a facial milk is prepared which contains 7% of liquid paraffin, 2% of powder according to Example 1, 3% of glyceryl monostearate, polyethylene glycol stearate, 0.4% of carboxyvinyl polymer, 0.7% of stearyl alcohol, 3% of soya-bean proteins, 0.4% of NaOH, a preservative and the balance to 100 is water.
• a facial gel is prepared which contains 10% of glycerin, 2% of powder according to Example 1, 1% of disodium cocoamphodiacetate, a preservative and the balance to 100 is water.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• Animal Behavior & Ethology (AREA)
• Epidemiology (AREA)
• Birds (AREA)
• Chemical & Material Sciences (AREA)
• Dermatology (AREA)
• Engineering & Computer Science (AREA)
• Mycology (AREA)
• Organic Chemistry (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Nutrition Science (AREA)
• Food Science & Technology (AREA)
• Polymers & Plastics (AREA)
• Gerontology & Geriatric Medicine (AREA)
• Microbiology (AREA)
• Biotechnology (AREA)
• Botany (AREA)
• Toxicology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Biochemistry (AREA)
• Emergency Medicine (AREA)
• Cosmetics (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
• Medicines Containing Plant Substances (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Medicinal Preparation (AREA)
• Coloring Foods And Improving Nutritive Qualities (AREA)
• Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)

Priority Applications (2)

Applications Claiming Priority (3)

Related Child Applications (1)

Publications (1)

Family

ID=34042882

Family Applications (3)

Family Applications After (2)

Country Status (14)

Cited By (1)

Families Citing this family (11)

Citations (6)

Family Cites Families (13)

• 2003
  • 2003-08-21 ES ES03018982T patent/ES2322757T3/es not_active Expired - Lifetime
  • 2003-08-21 DE DE60326571T patent/DE60326571D1/de not_active Expired - Lifetime
  • 2003-08-21 EP EP03018982A patent/EP1508325B1/fr not_active Expired - Lifetime
  • 2003-08-21 AT AT03018982T patent/ATE424898T1/de not_active IP Right Cessation
• 2004
  • 2004-08-20 KR KR1020067003440A patent/KR20060097107A/ko not_active Application Discontinuation
  • 2004-08-20 US US10/568,704 patent/US20060286187A1/en not_active Abandoned
  • 2004-08-20 CA CA2536240A patent/CA2536240C/en not_active Expired - Fee Related
  • 2004-08-20 CN CNB200480022980XA patent/CN100431523C/zh not_active Expired - Fee Related
  • 2004-08-20 WO PCT/EP2004/009349 patent/WO2005020948A1/fr active Application Filing
  • 2004-08-20 PL PL379091A patent/PL379091A1/pl not_active Application Discontinuation
  • 2004-08-20 JP JP2006523614A patent/JP4814094B2/ja not_active Expired - Fee Related
  • 2004-08-20 AU AU2004267942A patent/AU2004267942B2/en not_active Ceased
  • 2004-08-20 BR BRPI0413691-8A patent/BRPI0413691A/pt not_active Application Discontinuation
• 2006
  • 2006-03-20 ZA ZA200602277A patent/ZA200602277B/en unknown
• 2011
  • 2011-10-04 US US13/252,267 patent/US8507014B2/en not_active Expired - Fee Related
• 2013
  • 2013-07-10 US US13/938,872 patent/US8795743B2/en not_active Expired - Fee Related

Patent Citations (6)

Also Published As

Similar Documents

Legal Events